In a nutshell This study wanted to analyse how treatment with everolimus (Afintor) and exemestane (Aromasin) is performed in patients with breast cancer, and if there are any side effects. The study found that treatment occured for an average of 28 .5 weeks, and side effects were seen in a number of patients, including...
Read More
In a nutshell This study wanted to find out if performing radiation therapy on patients with breast cancer who have had surgery results in a lesser quality of life. The study found that the patients who had radiotherapy had a higher chance of having pain, swelling, skin problems and sensitivity in the area of the breast. Some background Breast cancer...
Read MoreIn a nutshell This trial aims to test the effectiveness of adding olaparib (Lynparza) to radiotherapy for inflammatory breast cancer. The main outcome measured will be how long the patients survive without the disease coming back in its invasive form. The study is being conducted in the United States. The details Inflammatory breast cancer can be...
Read More
In a nutshell This study want to see what type of surgery results in a higher chance of breast cancer coming back, fat grafting or breast reconstruction. The study found that both types of surgery resulted in an equal chance of the breast cancer coming back. Some background Fat grafting is a surgical way to fill in holes in the tissue of the breast...
Read More
In a nutshell This study wanted to look at the effect of exercise on patients with breast cancer. The study found that all types of exercise improved the fitness and tiredness levels of the patients. Some background Breast cancer and the treatments associated can be exhausting for the patients. This can lead to a decrease in their quality of life....
Read More
During July and early August of 2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...
Read More
In a nutshell This study wanted to find out if joint pain is associated with falling down in patients with breast cancer who were treated with aromatase inhibitors. The study found that the patients who reported having joint pain were more likely to have a fall than those who had no joint pain. Some background Aromatase inhibitors are medications...
Read MoreIn a nutshell This trial is aiming to determine how effective a new medication called elacestrant is for treating advanced breast cancer. The main outcome that will be measured is how long the patients go without the disease progressing. This study is being conducted in Illinois, United States. The details Some breast cancers grow in response to the...
Read More
In a nutshell This article investigated the long-term safety and effectiveness of oncoplastic breast surgery (removal of the tumor and breast reconstruction at the same time) on women survivors of breast cancer. The authors concluded that this treatment is safe and resulted in acceptable long-term outcomes. Some background Breast conservative...
Read More
In a nutshell This study wanted to find out if treating breast cancer with everolimus (Afintor) and endocrine therapy is better than only treating with endocrine therapy. The study found that using everolimus in addition to endocrine therapy had a significant benefit to survival in these patients. Some background Breast cancer is classified into types...
Read More
In a nutshell This trial is examining the effectiveness of a new type of surgical technique for mastectomy (surgical removal of the whole breast) in both breasts, followed by breast reconstruction. The main outcome that will be measured is blood flow in the operated area and pain. This study is recruiting in Baltimore, Maryland, in the United...
Read MoreIn a nutshell This study wanted to find out what the best length of treatment with trastuzumab (Herceptin) is for HER2+ early stage breast cancer. The study found that at least one year of treatment had the best results in terms of how well it worked, and the cost-effectiveness. Some background HER-2 positive breast cancer is a type of cancer where...
Read More
